Clinical Trial: A RWS of SC MTX in Chinese RA Patients

U.S., March 12 -- ClinicalTrials.gov registry received information related to the study (NCT07463937) titled 'A RWS of SC MTX in Chinese RA Patients' on Feb. 25.

Brief Summary: Design: A prospective, single-arm, multicenter, real-world study that does not interfere with the patient's treatment plan

Primary Objective:

1. To evaluate the effectiveness and safety of subcutaneous Methotrexate (MTX) in RA patients in a real-world setting;

Exploratory Objectives:

1. To assess the safety and effectiveness of subcutaneous MTX in RA patients with interstitial lung disease (ILD) or interstitial lung abnormalities (ILAs), and stable coronary artery disease (SCAD) in a real-world setting;

2. To evaluate the effectiveness and safety of subcutaneou...